David L. Johnson was elected President and CEO of the Central Indiana Corporate Partnership (CICP) in December 2012, and also continues to serve as President of its BioCrossroads life sciences initiative. Johnson has been engaged with CICP for nearly 15 years as one of the original organizers and chief executives of BioCrossroads, a market-based enterprise focused on strategic investments growing Indiana's life sciences sector.
Among its many activities, BioCrossroads informs and educates, raises and invests venture capital funds in promising new companies, and builds business collaborations by bridging gaps across academia and industry.
Through his work at BioCrossroads, Johnson has been responsible for raising over $325 million in philanthropic and venture capital funding to advance new companies, promote innovative research, and deliver on the promise of highly skilled 21st-century employment opportunities for Hoosiers. In his role as BioCrossroads President, Johnson has also been heavily involved in the evolution and management of CICP, allowing a seamless transition to lead this alliance of the region's (and state's) most influential employers and university presidents into major new undertakings. These include the launch of CICP's Ascend Indiana workforce initiative and the development of 16 Tech as a corporate and university innovation district to accelerate the pace of regional innovation and talent attraction.
A longtime business leader and lawyer, Johnson is an honors graduate of Harvard College, Harvard Law School, and Oxford University where he studied as a Rhodes Scholar.